Turgut Ozal Medical Center Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2013
NCT01827020
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Turgut Ozal University

Active Ingredients

Drugs in Phase 4 Trials (3)

ketamine (ketalar) (1 trial)

lidocaine (xylocaine) (1 trial)

sodium chloride (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Nose Deformities, Acquired (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3